PNC-27 research peptide |CAS 1159861-00-3 |API |life science supplier |"99% purity peptide supplier |research peptide
TDS 1 Inquiries
1159861-00-3
Pharmaceutical Grade
99%
GUANGZHOU
HKX
5mg
2027-02-01
Tirzepatide,Semaglutide,Retatrutide,MOTS-C,GHK-CU,MT-2
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferencePNC-27 is an anti-cancer peptide that, in small in-vitro studies, has been shown to induce tumour cell necrosis. It is not currently approved for use in the United States (U.S.) and is currently being marketed online as a non-toxic potential cure for various cancers. Recently, the FDA issued warnings to the public regarding PNC-27 use, suggesting possible contamination and unknown side effects of the treatment. PNC-27 may be available in various dosage forms, such as a nebulized solution, intravenous solution, vaginal suppository, or rectal suppository. FDA has not evaluated or approved PNC-27 as safe and effective in treating any disease, including cancer[1].
PNC-27 is an anticancer peptide, containing an HDM-2-binding domain. PNC-27 shows anti-tumor activity and can be used in acute myeloid leukemia research.Research & Reference NotePNC-27 research peptide |CAS 1159861-00-3 |API |life science supplier |"99% purity peptide supplier |research peptide is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Certificates-
TDS
Basic Info-
Product Name:
PNC-27
Other Name:PNC27
CAS No.:1159861-00-3
Molecular Weight:0
Categories:
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Semaglutide,Retatrutide,MOTS-C,GHK-CU,MT-2
-
Location:
203, NO. 88 Zhongxin North Road, Hangzhou Avenue Sub-district, Binhai New Area, Tianjin
-
Payment Terms:
TT against copy of documents,D/P,D/A,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
12
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
United States
PNC27
10 PCS Apr 11, 2026 Post an enquiry for this product